Chief Executive Officer
Biotechnology Startup In Drug Development And Ai
AeroLeads people directory · profile
Per Lindell Email & Phone Number
Chief Executive Officer
at
Biotechnology startup in drug development and AI
LinkedIn matched
✓ Verified Jun 2026
3 data sources
Profile completeness 86%
Current company
Role
Chief Executive Officer
Location
Chevy Chase, Maryland, United States
Who is Per Lindell? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Per Lindell is listed as Chief Executive Officer at Biotechnology startup in drug development and AI, based in Chevy Chase, Maryland, United States. AeroLeads shows a matched LinkedIn profile for Per Lindell.
Per Lindell previously worked as CEO (part time) at Stealth Biotech Startup In Ophthalmology and Managing Director at Novadigm Consulting Group. Per Lindell holds Sc.D. (Doctor Of Science, Same As A Ph.D. But In Engineering). Minor In Management Science., Biochemical Engineering, Management Science. from Massachusetts Institute Of Technology.
Company email context
Email format at Biotechnology startup in drug development and AI
This section adds company-level context without repeating Per Lindell's masked contact details.
Biotechnology startup in drug development and AI
Review company-level records connected to Per Lindell before choosing the right outreach path.
Profile bio
About Per Lindell
Management consultant and fractional management services to biopharma companies providing a broad set of services. Hands on management experience from Big Pharma, biotech companies, and as consultant COO for biotech companies. Consulting experience from Boston Consulting Group. Large industry network. Over 25 years broad experience in US, EU, Japan and Australia. Doctor of Science from MIT in Biochemical Engineering with minor in Management. Master of Science in Chemical Engineering from Royal Institute of Technology, Sweden. Consulting Experience from Boston Consulting Group, Arthur D. Little and IBM. Biopharma experience from Pharmacia, BASF Pharma and several biotech companies. Fulbright scholar. Member of the Umbrex, BiotechExcec and Alacrita consultant networks. Uniquely broad and deep experience both as a hands-on manager and consultant, in drug discovery, preclinical and clinical development (including IND filings and clinical trial management), biologics and gene therapy manufacturing, analytics and diagnostics, business and corporate development (large licensing and M&A deals), strategic planning (up to division level), portfolio management, product and therapeutic area strategies, major new product launches and commercial development planning, startup management and financing. Experienced negotiator including large business development deals and vendor management. As consultant, retained as personal advisor to large pharmaceutical company CEO and as acting COO for several biotech companies. Academic teaching at graduate level (MIT). Experience from most therapeutic modalities, including small molecules, peptides, biologics (especially monoclonal antibodies), gene and cell therapies (especially AAV) and RNA therapeutics. Experience in most therapeutic areas, including obesity, oncology, gastrointestinal (functional and IBD), infectious disease (including HCV and HBV), CNS & pain, ophthalmology, immunology including allergy & RA, cardiovascular and respiratory (including asthma). Experience managing biologics and gene therapy manufacturing, including AAV vectors. Recent experience in GLP-1, GIP, PYY, amylin and glucagon receptor agents for obesity and diabetes.Have managed 3 biotech companies as consultant COO/CEO.Have supported fundraising efforts in seed, series A and B, and Nasdaq listings and PIPEs. Contact: per.lindell@novadigmcg.com
Current workplace
Per Lindell's current company
Company context helps verify the profile and gives searchers a useful next step.
Biotechnology Startup In Drug Development And Ai
AeroLeads page
16 roles · 45 years
Per Lindell work experience
A career timeline built from the work history available for this profile.
Ceo (Part Time)
Current
Stealth Biotech Startup In Ophthalmology
Stealth startup biotechnology company using AI to develop drugs with very long duration of action for retinal diseases.
Jan 2022 - Present
Managing Director
Current
Novadigm Consulting Group
Providing a broad set of services to pharmaceutical and biotechnology companies, including drug design, pre-clinical and clinical development, biologics manufacturing, business development and corporate development (deal scouting, due diligence, execution and M&A), new product launches, strategic planning and financing (VC and IPO). Member of the Umbrex.
2011 - Present
~15 yrs 5 mos
Member Of Harvard Business Review Advisory Council
Current
Aug 2024 - Present
2023 - Present
~3 yrs 5 mos
2017 - Present
~9 yrs 5 mos
Practice Leader In The Pharmaceutical Industry Management Consulting Practice
Marketing, selling and executing management consulting services to Big Pharma clients, focusing on business development, strategic planning and portfolio management.
2010 - 2011
~1 yr
Independent Biotechnology Management Consultant
Independent Management Consultant
Provided management consulting services to biotechnology companies in business development, strategic planning, clinical development strategies and technology strategies. Consultant COO to public biotech companies in peptide therapeutics. Therapeutic areas included gastrointestinal, oncology, rheumatoid arthritis and autoimmunity, obesity and pain..
2007 - 2010
~3 yrs
Director
Managed Easton Associates marketing activities in parallel with an independent management consulting practice. Easton Associates is a biopharmaceutical management consulting firm founded from the former Wilkerson Group.
2008 - 2009
~1 yr
Vice President Corporate Development
Managed all corporate development activities for large public antisense company with lead product filed for market approval. Included both in- and out-licensing, acquisition and merger opportunities.
2005 - 2007
~2 yrs
Vice President Corporate Development
Metaphore Pharmaceuticals
Managed all corporate development activates for well funded biotechnology company with a superoxide dismutase mimetics platform which enhances cells management of free radicals. Indications included pain (lead indication in phase 2), inflammation, rheumatoid arthritis, autoimmunity, CNS and respiratory. Also managed CMC activities. Deep involvement with.
2004 - 2005
~1 yr
Vice President Business Development
Managed all business development activities for a well funded genomics drug discovery company in oncology. Included large Big Pharma partnership and several mid sized discovery partnerships. Also involved in technology strategy and drug development.
2001 - 2004
~3 yrs
Senior Director
Managed strategic planning department in parallel with several very large product development and launch projects as well as participated in business development projects. Managed product launches in stroke, obesity and pain, as well as in-and out licensing and large product divestment and acquisition projects (valued at over $1 Bn). Restructured strategic.
1998 - 2001
~3 yrs
Senior Manager
Worked in the Pharmaceutical and Technology and Innovation Management Practices, mainly for Big Pharma clients. Projects mainly focused on R&D strategy, strategic marketing, business development and M&A, and innovation management. Maintained key accounts. Several very large restructuring and strategy projects, in US and EU. Managed the.
1994 - 1998
~4 yrs
Consultant
Worked in the Pharmaceutical and Finance practices mainly for Big Pharma clients. Co-author on widely published industry reports.
1992 - 1994
~2 yrs
Research Engineer
Worked as a discovery scientist with monoclonal antibodies, mainly against anti-infective targets. Awarded Pharmacia full salary scholarship for Ph.D. studies.
1981 - 1985
~4 yrs
4 education records
Per Lindell education
Sc.D. (Doctor Of Science, Same As A Ph.D. But In Engineering). Minor In Management Science., Biochemical Engineering, Management Science.
Massachusetts Institute Of Technology
Master Of Science (M.Sc.), Chemical Engineering.
Kth Royal Institute Of Technology
Sergeant, Special Forces; Marine Ranger Officer/ Plutonsbefäl Kustjägare
Kustjägarskolan
High School Diploma, Electrical And Electronics Engineering
Kattegattskolan
FAQ
Frequently asked questions about Per Lindell
Quick answers generated from the profile data available on this page.
What company does Per Lindell work for?
Per Lindell works for Biotechnology startup in drug development and AI.
What is Per Lindell's role at Biotechnology startup in drug development and AI?
Per Lindell is listed as Chief Executive Officer at Biotechnology startup in drug development and AI.
Where is Per Lindell based?
Per Lindell is based in Chevy Chase, Maryland, United States while working with Biotechnology startup in drug development and AI.
What companies has Per Lindell worked for?
Per Lindell has worked for Biotechnology Startup In Drug Development And Ai, Stealth Biotech Startup In Ophthalmology, Novadigm Consulting Group, Harvard Business Review, and Alumni Ventures.
How can I contact Per Lindell?
You can use AeroLeads to view verified contact signals for Per Lindell at Biotechnology startup in drug development and AI, including work email, phone, and LinkedIn data when available.
What schools did Per Lindell attend?
Per Lindell holds Sc.D. (Doctor Of Science, Same As A Ph.D. But In Engineering). Minor In Management Science., Biochemical Engineering, Management Science. from Massachusetts Institute Of Technology.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial